AngioDynamics Inc logo

ANGO - AngioDynamics Inc Share Price

$15.48 0.1  0.5%

Last Trade - 17/01/20

Sector
Healthcare
Size
Mid Cap
Market Cap £443.1m
Enterprise Value £411.6m
Revenue £191.5m
Position in Universe 2908th / 6416
Bullish
Bearish
Unlock ANGO Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ANGO Revenue Unlock ANGO Revenue

Net Income

ANGO Net Income Unlock ANGO Revenue

Normalised EPS

ANGO Normalised EPS Unlock ANGO Revenue

PE Ratio Range

ANGO PE Ratio Range Unlock ANGO Revenue

Dividend Yield Range

ANGO Dividend Yield Range Unlock ANGO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ANGO EPS Forecasts Unlock ANGO Revenue
Profile Summary

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.

Directors
Last Annual May 31st, 2019
Last Interim November 30th, 2019
Incorporated July 30, 1992
Public Since May 27, 2004
No. of Shareholders: 180
No. of Employees: 750
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 37,625,690
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ANGO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ANGO
Upcoming Events for ANGO
Similar to ANGO
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.